ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1434

Multiomic Study of Skin, Peripheral Blood and Serum: Is Serum Proteome a Reflection of Disease Process at the End-Organ Level in Systemic Sclerosis?

Victor Farutin1, Elma Kurtagic2, Joel Pradines3, Ishan Capila3, Maureen Mayes4, Minghua Wu5, Anthony Manning3 and Shervin Assassi6, 1Janssen R&D, LLC, Watertown, MA, 2Janssen R&D, LLC, Cambridge, 3Momenta Pharmaceuticals, Inc., Cambridge, MA, 4Division of Rheumatology and Clinical Immunogenetics, University of Texas McGovern Medical School, Houston, TX, 5University of Texas Health Science Center at Houston, Houston, TX, 6University of Texas McGovern Medical School at Houston, Houston, TX

Meeting: ACR Convergence 2021

Keywords: Gene Expression, proteomics, Scleroderma, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Abstracts: Systemic Sclerosis & Related Disorders – Basic Science (1434–1437)

Session Type: Abstract Session

Session Time: 10:30AM-10:45AM

Background/Purpose: Discovery of biomarkers in systemic sclerosis (SSc) represents an unmet clinical need. Samples from prominently affected fibrotic end-organs such as lung and skin are not readily available whereas serum proteins are assessed during routine clinical care. However, it is unclear to what extent serum proteins reflect the molecular dysregulations of peripheral blood cells (PBCs) or affected end-organs. This study describes multiomic comparative analysis of SSc serum proteomic profile as well as gene expression analysis of PBC and skin biopsies in concurrently collected samples from SSc patients and healthy controls.

Methods: Global gene expression profiling on Illumina HumanHT-12 BeadChip was carried out in skin and PBC samples obtained from 49 patients and 25 unaffected controls. Levels of 911 proteins were determined in concurrently collected serum samples with Olink Proximity Extension Assay (PEA) technology.

Results: SSc serum profile revealed an upregulation of proteins involved in pro-fibrotic, homing and extravasation, as well as extracellular matrix components/modulators. Notably, several soluble receptor proteins such as EGFR, ERBB2, ERBB3, VEGFR2, TGFBR3, and PDGF-Rα were downregulated. Thirty-nine proteins correlated with severity of SSc skin disease as assessed by modified Rodnan Skin Score (mRSS) (FDR< 5%). There was a significant correlation between direction of differential expression of serum proteins in SSc vs. control comparison and their association with mRSS (ρ=0.59, permutation p< 0.0001) (Fig. 1). Correlative analysis of differences between SSc patients and healthy controls among the three datasets demonstrated that:

1) The differential expression of serum protein in SSc vs. control comparison significantly correlated with the differential expression of corresponding transcripts in skin but not in PBCs (p=0.014 vs. p=0.24) (Fig 2A).

2) The differentially expressed serum proteins represented more significant Well-Associated-Proteins (WAP) (Pradines et al. PMC7046299) in the skin than in PBC gene expression dataset, as demonstrated by lower WAP scores in the skin tissue (Fig. 2B).

3) The assessment of the concordance of between-sample similarities at the entire dataset level revealed that the molecular profile of serum proteins and skin gene expression data were significantly concordant in SSc patients but not in healthy controls. On the contrary, the concordance of similarities between serum protein and PBC gene expression profiles was most pronounced in healthy controls and notably reduced in patients, suggesting disruption of correlation between the serum proteome and PBC transcriptome in SSc patients, contrary to healthy controls due to spill-over effect from skin. (Fig 3).

Conclusion: In this first multiomic cross-comparison of SSc serum proteins, PBC transcriptome and skin transcriptome in concurrently collected samples, the serum protein profile correlated more closely with molecular dysregulations of skin than PBCs, supporting the notion that it might serve as a reflection of disease severity at the end-organ level.

Serum proteins associations with disease and mRSS: a) Volcano plot of SSc-Cont differences; b) Volcano plot of correlation with mRSS in SSc patients; c) Scatterplot of serum proteins associations with mRSS vs. SSc-Cont differences; d) Permutation-based significance of the correlation between serum protein associations with mRSS and SSc-Cont differences. Vertical red dashes in panel d) indicate observed correlation between mRSS and disease effects on serum proteome; histogram represents distribution of such correlations obtained for randomly permuted sample annotation. Text labels in panel c) indicate proteins associated at BH-FDR < 5% both with mRSS and disease.

SSc-Cont differences for the serum proteins are significantly associated with SSc-Cont differences in skin: a) SSc-Cont differences are positively correlated between serum proteins and corresponding skin transcripts; b) WAP score ranks of differentially expressed serum proteins for SSc-Cont differences in skin and in PBC (lower values of rank represent more significant WAPs). The WAP ranking is generated based on prior knowledge in the form of protein-protein interaction networks.

Concordance of between samples similarities (as Spearman correlations) for each pairwise combination of the three datasets: serum proteins, PBC transcripts and skin transcripts. Top row displays results for healthy controls, bottom row – for SSc patients. Mantel test results (vertical red dashes represent the observed concordance of between sample similarities for the actual mapping of samples to subjects) are compared to their corresponding null distributions (obtained by randomly permuting assignment of samples to subjects in each dataset).


Disclosures: V. Farutin, Janssen Pharmaceutical Companies of Johnson & Johnson, 3, 11, Momenta Pharmaceuticals, Inc., 3, 11; E. Kurtagic, Johnson & Johnson, 3, 11; J. Pradines, Takeda Pharmaceuticals, 3; I. Capila, Johnson and Johnson, 12, Share holding, Momenta Pharmaceuticals, 12, Share holding; M. Mayes, Actelion Pharma, 1, Mitsubishi-Tanabe, 1, Corbus Pharma, 5, Boehringer-Ingelheim, 1, 5, Eicos, 1, 5, Galapagos Pharma, 1, 5; M. Wu, None; A. Manning, None; S. Assassi, Novartis, 2, Boehringer Ingelheim, 2, 5, 6, 12, Travel, Corbus, 2, Integrity Continuing Education, 6, Medscape, 6, Momenta, 5, CSL Behring, 2, Janssen, 5, Abbvie, 2.

To cite this abstract in AMA style:

Farutin V, Kurtagic E, Pradines J, Capila I, Mayes M, Wu M, Manning A, Assassi S. Multiomic Study of Skin, Peripheral Blood and Serum: Is Serum Proteome a Reflection of Disease Process at the End-Organ Level in Systemic Sclerosis? [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/multiomic-study-of-skin-peripheral-blood-and-serum-is-serum-proteome-a-reflection-of-disease-process-at-the-end-organ-level-in-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/multiomic-study-of-skin-peripheral-blood-and-serum-is-serum-proteome-a-reflection-of-disease-process-at-the-end-organ-level-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology